PHH
Park Ha Biological Technology Co., Ltd. Ordinary SharesPHH
PHH
About: Park Ha Biological Technology Co Ltd is engaged in developing its private skincare label, direct skincare products sales and franchise alliances promotions. Its Park Ha brand focuses on providing solutions for problematic skin. The company's Operating Subsidiaries provide skincare and cosmetic products under its brand, Park Ha in China. Its Operating Subsidiaries develop its proprietary beauty products and offer complimentary after-sales beauty services in its physical stores.
Employees: 31
0
Funds holding %
of 7,419 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
0.31% more ownership
Funds ownership: 0% [Q3] → 0.31% (+0.31%) [Q4]
Research analyst outlook
We haven’t received any recent analyst ratings for PHH.
Financial journalist opinion
Neutral
GlobeNewsWire
3 months ago
Park Ha Biological Technology Co., Ltd. Announces Closing of $4.8 Million Initial Public Offering
Wuxi, China, Dec. 30, 2024 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd. (Nasdaq: PHH) (the “Company”), a company focused on developing private skincare labels, direct skincare product sales, and franchise alliance promotions, today announced the closing of its initial public offering (the “Offering”) of 1,200,000 ordinary shares (the “Ordinary Shares”) at a public offering price of $4.00 per ordinary share. The Ordinary Shares began trading on the Nasdaq Capital Market on December 27, 2024 under the ticker symbol “PHH.”
Neutral
GlobeNewsWire
3 months ago
Park Ha Biological Technology Co., Ltd. Announces Pricing of $4.8 Million Initial Public Offering
Wuxi, China, Dec. 26, 2024 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd. (the "Company"), a company focused on developing private skincare labels, direct skincare product sales, and franchise alliance promotions, today announced the pricing of its initial public offering (the "Offering") of 1,200,000 ordinary shares at a public offering price of $4.00 per ordinary share. The ordinary shares have been approved for listing on the Nasdaq Capital Market and are expected to commence trading on December 27, 2024 under the ticker symbol "PHH."
Negative
Seeking Alpha
5 months ago
Park Ha Biological Aims For U.S. IPO At Sky-High Valuation
Park Ha Biological Technology Co., Ltd. seeks $6 million in an IPO, but has wildly excessive valuation expectations given its small size and fluctuating financial metrics. The company faces numerous regulatory and market risks, with declining revenues and high franchisee turnover, adding doubt to its business model structure. Park Ha's financial performance shows variable revenue, reduced gross profit and sharply lower cash flow.
Neutral
Seeking Alpha
7 months ago
U.S. IPO Weekly Recap: Small Issuers Close Out August IPO Market
While major IPOs are on hold until after Labor Day, three small deals were completed in the last week of August. Two SPACs, GigCapital7 and Black Spade Acquisition II, raised $200 million and $150 million, respectively. Three IPOs are currently scheduled to list in the week ahead, all of them holdovers from previous weeks, and all based in the Asia Pacific region.
Charts implemented using Lightweight Charts™